Combining efficiency and safety in high-potent drug substance manufacturing

Laurus Synthesis has proven expertise in the manufacture of high-potent APIs and intermediates, at both pilot and commercial scale. Our dedicated high-potent cGMP manufacturing facilities can support small-scale synthesis as well as commercial-scale manufacturing. The facilities are designed to enable operational containment levels of Occupational Exposure Levels (OEL) <1mg /m3. In total, Laurus has a capacity of>300KL for high-potent drug substance manufacturing (Cytotoxic & steroidal hormones).